Mtm Investment Management, LLC Amgen Inc Transaction History

Mtm Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $196,294 - $224,641	-987 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$212.27 - $248.7 $12,736 - $14,922	-60 Reduced 5.73%	987 $210,000
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $189,666 - $210,421	-812 Reduced 43.68%	1,047 $255,000
Q1 2021 Apr 19, 2021	BUY	$221.91 - $258.6 $92,758 - $108,094	418 Added 29.01%	1,859 $463,000
Q4 2020 Jan 27, 2021	BUY	$216.38 - $257.67 $311,803 - $371,302	1,441 New	1,441 $331,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mtm Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Mtm Investment Management, LLC with notifications on news.